They are not simply two names for the same healing peptide. The clearest way to see the divergence is by the kind of neuro-outcome each is best evidenced for: BPC-157 is best supported for peripheral-nerve regeneration and CNS neuroprotection : accelerating axonal regrowth in transected peripheral nerve, sparing tissue and limiting edema after brain and spinal-cord injury, and supporting repair through VEGFR2/NO-mediated angiogenesis, with an additional braingut neuromodulatory layer
The practical impact is minimal
There is no single correct amount more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately
In addition to functioning as a reversible electron carrier, it participates directly in the catalytic activity of multiple NAD+-dependent enzyme families
Most experts recommend limiting use to twelve weeks followed by an equal rest period
This combination is frequently utilized in research settings to investigate potential synergistic effects on cellular migration, actin sequestration, and angiogenesis pathways